Fusion Protein Assay for Intracellular Binding Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying protein binding events in cells are limited by their inability to easily detect weak interactions, require expensive and time-consuming processes, and are not amenable to high-throughput screening, especially for identifying interaction interfaces and stabilizing or destabilizing proteins effectively.
Innovation Solution
A method involving the creation of a fusion protein with a target peptide and a labeling peptide in a mammalian cell, where the target peptide has a destabilizing mutation, allowing for the assessment of compound binding by measuring changes in the abundance of the fusion protein through enzyme fragment complementation, specifically using β-galactosidase fragments for detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods are used to study protein binding events, then detection capability is limited, but cost and time consumption increase
Solution Approach 1:
The patent replaces complex mechanical and manual detection systems with a biochemical assay system. The fusion protein approach combines the target peptide with a destabilizing domain and reporter protein, allowing binding events to be detected through changes in protein stability and reporter signal intensity, eliminating the need for time-consuming manual methods while improving detection sensitivity
Solution Approach 2:
The patent changes the stability parameter of the target peptide by introducing a destabilizing domain that makes the peptide rapidly degraded unless bound to a binding partner. This parameter change converts subtle binding events into large, easily measurable changes in protein abundance and reporter signal, improving detection capability while reducing analysis time
2Measurement precision
If current methods are used to study protein binding events, then detection capability is limited, but expense increases
Solution Approach 1:
The patent replaces expensive mechanical detection systems and manual procedures with a biochemical reporter assay. The fusion protein system with destabilizing domain and reporter protein enables detection through simple luminescence or fluorescence measurements, significantly reducing equipment and operational costs while maintaining or improving detection sensitivity
Solution Approach 2:
The patent employs a destabilizing domain that creates a short-lived fusion protein with rapid turnover. This approach uses inexpensive, rapidly degraded protein constructs that require minimal resources, replacing expensive stable protein systems while enabling sensitive detection through the contrast between degraded and stabilized states
3Productivity
If current methods are used for high-throughput screening, then screening capability is reduced, but complexity of process increases
Solution Approach 1:
The patent segments the detection process into distinct functional modules: the target peptide with destabilizing domain, the reporter protein, and the binding partner. This segmentation allows each component to be independently optimized and enables parallel processing in high-throughput formats, increasing screening capacity while maintaining manageable process complexity through modular design
Solution Approach 2:
The patent changes the abundance parameter of the fusion protein through controlled stabilization upon binding. This parameter change creates a clear, quantifiable readout that can be rapidly measured in high-throughput formats using standard plate readers, enabling efficient screening without requiring complex specialized equipment or procedures
4Measurement precision
If destabilizing mutation is introduced in target peptide, then sensitivity of detection improves, but protein stability decreases
Solution Approach 1:
The patent introduces dynamic control of protein stability through the destabilizing domain. The fusion protein exists in a dynamic equilibrium between synthesis and rapid degradation, with its stability state being dynamically adjusted by binding events. This dynamic system converts stable but undetectable protein-protein interactions into dynamic, easily measurable changes in protein abundance and reporter signal
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables sensitive and physiologically relevant assays for monitoring protein binding and stability, facilitating the identification of interaction interfaces and screening of small molecules as inhibitors, thereby supporting drug development for various human disorders.
Implementation Method 1
measuring changes in the abundance of the fusion protein through enzyme fragment complementation, specifically using β-galactosidase fragments for detection
Data Source
Figure 1
Figure 2
Figure 3~4
AI summary
Methods and compositions are provided to measure the binding of a test compound to a target peptide by measuring the effect of the compound on the abundance of the target peptide inside a cell. The target peptide may bind the test compound at an active site or an allosteric site, and it has been found that such binding may stabilize the target peptide against cellular degradation. The target peptide will preferably comprise a destabilizing mutation which shortens the half life of the target peptide within the cell, typically a mammalian cell. Test compounds, including small molecules, have been found to stabilize target peptides. Also provided are systems and kits for use in practicing the methods.